Latest Women’s Health News
If you are looking for information, tips, and answers to women’s health questions, you have come to the right place. As a program of the Cleveland Clinic Center for Specialized Women’s Health, we can offer you expert advice and current articles from the women’s health community about maturing women related health topics, including:
- Dietary concerns
- Menopause management
- Necessary medical tests
- Osteoporosis prevention
You’ll also find cutting edge women’s health news from the Cleveland Clinic, as well as developments from other women’s health news outlets all within the Speaking of Women’s Health community section.
Make sure to stay up-to-date on current women’s health news, articles and videos by viewing the releases below.
July 2017 - If type 2 diabetes is part of your life—whether you have the condition or are at risk of developing it—you’ve probably heard of a drug called metformin. Perhaps your doctor has told you about it, has recently started you on it or has been prescribing it to you for years to keep your blood sugar under control.
It’s no newbie. Metformin has been available by prescription in the US for more than 20 years and in Europe for more than 40 years. US doctors write nearly 60 million prescriptions a year. It’s recommended as the go-to-first prescription for people with diabetes by the American Diabetes Association, the American Association of Clinical Endocrinologists and the American College of Physicians.Read more…
June 2017 -- “Hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture,” says Dr. JoAnn V. Pinkerton, NAMS Executive Director and Chair of the Position Statement Advisory Panel. “NAMS discovered through its review of the literature published since the 2012 Position Statement that its previous position that hormone therapy should be prescribed only for the ‘lowest dose for the shortest period of time’ may be inadequate or even harmful for some women. NAMS has clarified this position to the more fitting concept of the ‘appropriate dose, duration, regimen, and route of administration’ that provides the most benefit with the minimal amount of risk.”Read more…
An analysis of 17 past studies suggests that while breast-feeding for any period of time appears to lower a woman’s risk of endometrial cancer, mothers who breast-fed for the recommended six months lowered their risk even further.
Surpassing the 6-9 month recommended timeframe for breast-feeding seemed to have little benefit, the researchers said, but those who had ever breast-fed their children were 11 percent less likely than women who had children but didn’t breast-feed to be diagnosed with endometrial cancer, Reuters reported.Read more…
This review summarizes how ERAAs can be used in combination with an estrogen or alone to treat menopausal symptoms (vasomotor symptoms, genitourinary syndrome of menopause), breast cancer or the risk of breast cancer, osteopenia, osteoporosis, and other female midlife concerns.Read more…
Dr. Holly L. Thacker discusses how to take control of your sensitive bladder with Dr. Mache Seibel in the latest issue of The Hot Years: My Menopause magazine.Read more…
Ahah is a non-profit foundation dedicated to the health of women who have had a hysterectomy. In the USA, there are 8 million such women who are under age 60 with half of them age 45 or younger. On behalf of these women, we would urge the USPSTF not to suggest that estrogen therapy (ET) deserves a grade of D for disease prevention because the totality of recent data supports a higher grade. Consider the following:Read more…
Radius Health (RDUS) Announces FDA Approval for TYMLOS for Treatment of Postmenopausal Women with Osteoporosis
April 2017 - Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases, today announced that the US Food and Drug Administration (FDA) has approved TYMLOS (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, TYMLOS reduces the risk of vertebral and nonvertebral fractures.Read more…
If you would like more information about the VeLVET Study or if you are interested in participating, please call The Cleveland Clinic Department of Ob/Gyn and Women’s Health Institute research line, at 216-445-8090.Read more…
April 2017 - A widely shared story that U.S. health officials are recommending a delay in breast-feeding to improve vaccine effectiveness is false.
The U.S. Centers for Disease Control and Prevention, the agency named in the false reports, encourages breastfeeding. The CDC says breast milk is best for all infants except in rare cases such as when a mother has active, untreated tuberculosis.Read more…
April 2017 - Infants born to mothers who are vaccinated against the highly contagious and potentially fatal whooping cough are much less likely to get it than others, researchers said, in a large study published Monday.
Whooping cough, which is caused by Bordetella pertussis bacteria, is easily spread when an infected individual coughs or sneezes. About half of infants who contract the illness require hospitalization for complications like pneumonia or brain disorder, Reuters reported.Read more…